My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Apple Gets Early Formula 1 Ratings Win: Are F...
What Industry Disruption? Zillow Has Durable...
Ulta Beauty Announces Strong Q4, Disappointin...
Consumer Fears Of Inflation Spike After Iran...
Apple Slashes App Store Fees In China To Dodg...
PayPay Stock Surges Amid Post-IPO Fluctuation...
Kroger Shares Rise As Pharmacies Add Eli Lill...
Hormuz Turned Fertilizer Into The New Shortag...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    AMGEN INC (NASDAQ: AMGN)

    Overview
    current price
    $366.21
    $366.21
    change
    -1.58 | -0.43%
    -1.58 | -0.43%
    Yesterday's Close
    367.79
    open
    370.68
    volume
    1.50 M
    30d. avg volume.
    2.86 M
    1 day
    365.93 - 372.98
    52 weeks
    261.43 - 391.29
    p/e
    25.74
    beta
    0.4509
    market cap
    197.41 B
    dividend yield
    2.75%
    Industry
    -
    AMGN by TradingView
    News and Commentary
    Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs? President Donald Trump just dropped a political bomb into one of Wall Street's hottest trades. His promise to cut the cost of Novo Nordisk A/S
    Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on...
    Market Update: Dow Climbs 100 Points as Year-End Strength Continues Stocks climbed higher Tuesday, even as investors grew concerned over the threat of new tariffs from President-elect Donald Trump. The Dow Jones Industrial Average rose over 100 p...
    Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs The Biden-Harris Administration has proposed expanding Medicare and Medicaid coverage for anti-obesity medications, aiming to address the high costs that have drawn criticism. In...
    Nvidia Joining Dow Jones Industrial Average: Where Tech Giant Ranks In The Index, Why Sherwin-Willia... Technology giant NVIDIA Corp (
    AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains AbbVie Inc (ABBV ...
    Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administrati...
    From Years to Months: How AI is Shaping the Landscape of Clinical Trials Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significan...
    FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal The Federal Trade Commission (FTC) decided to momentarily halt its challenge against pharmaceutical giant Amgen, Inc
    Rising Stars, Falling Trends: July's Industry ETF Winners and Losers As July comes to an end, it's time to take a look at the best- and worst-performing industry ETFs for the month.Among the largest ETFs that represent ma...
    StockTwits
    StockTwits
    Most Shared
    AI Giants Are Buying The World's Memory, And You're Getting The Bill
    Tesla's FSD Safety Metrics 'Sharply Deteriorating,' Says Analyst
    Trump's Global Tariff Kicks In At 10% From Tuesday, Instead Of 15%
    Most Popular
    AI Is Rewriting Market Leadership — Goldman Says HALO Stocks Are The Big Winners
    AI Giants Are Buying The World's Memory, And You're Getting The Bill
    Burger King Tests AI Tracking Employee Courtesy: Will Extra 'Please' And 'Thank Yous' Lift The Stock?
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Coronavirus Impact
    Tesla
    Google
    Covid-19
    China
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?